{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:56:09Z","timestamp":1793058969289,"version":"4.5.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T00:00:00Z","timestamp":1510617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,1]]},"DOI":"10.1093\/jnci\/djx225","type":"journal-article","created":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T19:11:55Z","timestamp":1506539515000},"page":"501-508","source":"Crossref","is-referenced-by-count":142,"title":["Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening"],"prefix":"10.1093","volume":"110","author":[{"given":"Mark","family":"Schiffman","sequence":"first","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter K","family":"Kinney","sequence":"additional","affiliation":[{"name":"Regional Laboratory, The Permanente Medical Group, Oakland, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li C","family":"Cheung","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia C","family":"Gage","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Fetterman","sequence":"additional","affiliation":[{"name":"Regional Laboratory, The Permanente Medical Group, Oakland, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E","family":"Poitras","sequence":"additional","affiliation":[{"name":"Regional Laboratory, The Permanente Medical Group, Oakland, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S","family":"Lorey","sequence":"additional","affiliation":[{"name":"Regional Laboratory, The Permanente Medical Group, Oakland, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Befano","sequence":"additional","affiliation":[{"name":"Information Management Services, Calverton, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Schussler","sequence":"additional","affiliation":[{"name":"Information Management Services, Calverton, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hormuzd A","family":"Katki","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip E","family":"Castle","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,11,14]]},"reference":[{"issue":"9590","key":"key\n\t\t\t\t20180510195524_djx225-B1","first-page":"890","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet."},{"issue":"5","key":"key\n\t\t\t\t20180510195524_djx225-B2","first-page":"1095","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int J Cancer."},{"issue":"16","key":"key\n\t\t\t\t20180510195524_djx225-B3","first-page":"1579","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N Engl J Med."},{"issue":"16","key":"key\n\t\t\t\t20180510195524_djx225-B4","first-page":"1589","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"Naucler","year":"2007","journal-title":"N Engl J Med."},{"issue":"1","key":"key\n\t\t\t\t20180510195524_djx225-B5","first-page":"78","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: Final results of the POBASCAM randomised controlled trial","volume":"13","author":"Rijkaart","year":"2012","journal-title":"Lancet Oncol."},{"issue":"3","key":"key\n\t\t\t\t20180510195524_djx225-B6","first-page":"249","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: A randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol."},{"issue":"9","key":"key\n\t\t\t\t20180510195524_djx225-B7","first-page":"880","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25\u2009years and older: A subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol."},{"issue":"2","key":"key\n\t\t\t\t20180510195524_djx225-B8","article-title":"Optimal cervical cancer screening in women vaccinated against human papillomavirus","volume":"109","author":"Kim","year":"2017","journal-title":"J Natl Cancer Inst."},{"issue":"2","key":"key\n\t\t\t\t20180510195524_djx225-B9","first-page":"178","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance","volume":"136","author":"Huh","year":"2015","journal-title":"Gynecol Oncol."},{"issue":"3","key":"key\n\t\t\t\t20180510195524_djx225-B10","first-page":"147","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin."},{"issue":"2","key":"key\n\t\t\t\t20180510195524_djx225-B11","first-page":"311","article-title":"Increased cervical cancer risk associated with screening at longer intervals","volume":"125","author":"Kinney","year":"2015","journal-title":"Obstet Gynecol."},{"issue":"12","key":"key\n\t\t\t\t20180510195524_djx225-B12","first-page":"55","article-title":"Making sense of cervical cancer screening guidelines and recommendations","volume":"16","author":"Davis","year":"2015","journal-title":"Curr Treat Options Oncol."},{"issue":"4","key":"key\n\t\t\t\t20180510195524_djx225-B13","first-page":"569","article-title":"The potential harms of primary human papillomavirus screening in over-screened women: A microsimulation study","volume":"27","author":"Naber","year":"2016","journal-title":"Cancer Causes Control."},{"issue":"6","key":"key\n\t\t\t\t20180510195524_djx225-B14","first-page":"606","article-title":"The clinical and economic benefits of co-testing versus primary hpv testing for cervical cancer screening: A modeling analysis","volume":"25","author":"Felix","year":"2016","journal-title":"J Womens Health (Larchmt)"},{"issue":"5","key":"key\n\t\t\t\t20180510195524_djx225-B15","first-page":"282","article-title":"Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices","volume":"123","author":"Blatt","year":"2015","journal-title":"Cancer Cytopathol."},{"issue":"7","key":"key\n\t\t\t\t20180510195524_djx225-B16","first-page":"428","article-title":"Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory","volume":"123","author":"Zheng","year":"2015","journal-title":"Cancer Cytopathol."},{"issue":"7","key":"key\n\t\t\t\t20180510195524_djx225-B17","first-page":"421","article-title":"History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: Experience from the largest women's hospital in China","volume":"123","author":"Tao","year":"2015","journal-title":"Cancer Cytopathol."},{"key":"key\n\t\t\t\t20180510195524_djx225-B18","author":"US Preventive Services Task Force","year":"2015"},{"issue":"2","key":"key\n\t\t\t\t20180510195524_djx225-B19","first-page":"87","article-title":"Preparing for the next round of ASCCP-sponsored cervical screening and management guidelines","volume":"21","author":"Schiffman","year":"2017","journal-title":"J Low Genit Tract Dis."},{"key":"key\n\t\t\t\t20180510195524_djx225-B20","first-page":"F117","article-title":"Introduction of human papillomavirus DNA screening in the world: 15\u2009years of experience","volume":"30(suppl 5","author":"Castle","year":"2012","journal-title":"Vaccine."},{"issue":"2","key":"key\n\t\t\t\t20180510195524_djx225-B21","first-page":"304","article-title":"Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening","volume":"103","author":"Wright","year":"2004","journal-title":"Obstet Gynecol."},{"issue":"7","key":"key\n\t\t\t\t20180510195524_djx225-B22","first-page":"663","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: A population-based study in routine clinical practice","volume":"12","author":"Katki","year":"2011","journal-title":"Lancet Oncol."},{"issue":"8","key":"key\n\t\t\t\t20180510195524_djx225-B23","article-title":"against future risk of precancer and cancer conferred by a negative human papillomavirus test","volume":"106","author":"Gage","year":"2014","journal-title":"J Natl Cancer Inst."},{"issue":"4","key":"key\n\t\t\t\t20180510195524_djx225-B24","first-page":"223","article-title":"2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ","volume":"11","author":"Wright","year":"2007","journal-title":"J Low Genit Tract Dis."},{"issue":"4","key":"key\n\t\t\t\t20180510195524_djx225-B25","first-page":"201","article-title":"2006 consensus guidelines for the management of women with abnormal cervical screening tests","volume":"11","author":"Wright","year":"2007","journal-title":"J Low Genit Tract Dis."},{"issue":"16","key":"key\n\t\t\t\t20180510195524_djx225-B26","first-page":"2120","article-title":"2001 Consensus Guidelines for the management of women with cervical cytological abnormalities","volume":"287","author":"Wright","year":"2002","journal-title":"JAMA."},{"issue":"4","key":"key\n\t\t\t\t20180510195524_djx225-B27","first-page":"829","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"121","author":"Massad","year":"2013","journal-title":"Obstet Gynecol."},{"issue":"10","key":"key\n\t\t\t\t20180510195524_djx225-B28","first-page":"1031","article-title":"Cervical cancer trends in the United States: A 35-year population-based analysis","volume":"21","author":"Adegoke","year":"2012","journal-title":"J Womens Health (Larchmt)."},{"issue":"5","key":"key\n\t\t\t\t20180510195524_djx225-B29","first-page":"317","article-title":"Clinical performance of the Food and Drug Administration-approved high-risk HPV test for the detection of high-grade cervicovaginal lesions","volume":"124","author":"Zhou","year":"2016","journal-title":"Cancer Cytopathol."},{"issue":"6","key":"key\n\t\t\t\t20180510195524_djx225-B30","first-page":"776","article-title":"Squamous cell carcinoma of the cervix: A cytology-histology-human papillomavirus correlation in clinical practice","volume":"139","author":"Miller","year":"2015","journal-title":"Arch Pathol Lab Med."},{"issue":"11","key":"key\n\t\t\t\t20180510195524_djx225-B31","first-page":"1431","article-title":"Glandular lesions of the cervix in clinical practice: A cytology, histology, and human papillomavirus correlation study from 2 institutions","volume":"139","author":"Miller","year":"2015","journal-title":"Arch Pathol Lab Med."},{"key":"key\n\t\t\t\t20180510195524_djx225-B32","first-page":"a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: Joint European cohort study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ."},{"issue":"10","key":"key\n\t\t\t\t20180510195524_djx225-B33","first-page":"935","article-title":"Trials comparing cytology with human papillomavirus screening","volume":"10","author":"Arbyn","year":"2009","journal-title":"Lancet Oncol."},{"issue":"13","key":"key\n\t\t\t\t20180510195524_djx225-B34","first-page":"4717","article-title":"Spontaneous regression of high-grade cervical dysplasia: Effects of human papillomavirus type and HLA phenotype","volume":"11","author":"Trimble","year":"2005","journal-title":"Clin Cancer Res."},{"issue":"1","key":"key\n\t\t\t\t20180510195524_djx225-B35","first-page":"18","article-title":"Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet Gynecol."},{"issue":"9509","key":"key\n\t\t\t\t20180510195524_djx225-B36","first-page":"489","article-title":"Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: Systematic review and meta-analysis","volume":"367","author":"Kyrgiou","year":"2006","journal-title":"Lancet."},{"issue":"9","key":"key\n\t\t\t\t20180510195524_djx225-B37","first-page":"1191","article-title":"Is the increased risk of preterm birth following excision for cervical intraepithelial neoplasia restricted to the first birth post treatment?","volume":"122","author":"Castanon","year":"2015","journal-title":"BJOG."},{"issue":"9","key":"key\n\t\t\t\t20180510195524_djx225-B38","first-page":"1426","article-title":"Risk of preterm birth following surgical treatment for cervical disease: Executive summary of a recent symposium","volume":"123","author":"Sasieni","year":"2016","journal-title":"BJOG."},{"key":"key\n\t\t\t\t20180510195524_djx225-B39","first-page":"232","article-title":"How many preterm births in England are due to excision of the cervical transformation zone? Nested case control study","volume":"15","author":"Wuntakal","year":"2015","journal-title":"BMC Pregnancy Childbirth."},{"issue":"3","key":"key\n\t\t\t\t20180510195524_djx225-B40","first-page":"175","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"16","author":"Saslow","year":"2012","journal-title":"J Low Genit Tract Dis."},{"issue":"2","key":"key\n\t\t\t\t20180510195524_djx225-B41","first-page":"129","article-title":"Secondary prevention of cervical cancer: American Society of Clinical Oncology resource-stratified clinical practice guideline summary","volume":"13","author":"Jeronimo","year":"2017","journal-title":"J Oncol Pract."},{"issue":"1","key":"key\n\t\t\t\t20180510195524_djx225-B42","first-page":"4","article-title":"HPV primary cervical screening: Time for a change","volume":"26","author":"Kitchener","year":"2015","journal-title":"Cytopathology."},{"issue":"1","key":"key\n\t\t\t\t20180510195524_djx225-B43","first-page":"9","article-title":"Primary HPV testing: A proposal for co-testing in initial rounds of screening to optimise sensitivity of cervical cancer screening","volume":"28","author":"Herbert","year":"2017","journal-title":"Cytopathology."},{"issue":"23","key":"key\n\t\t\t\t20180510195524_djx225-B44","first-page":"3682","article-title":"The population impact of human papillomavirus\/cytology cervical cotesting at 3-year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen","volume":"122","author":"Silver","year":"2016","journal-title":"Cancer."}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/110\/5\/501\/24797249\/djx225.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T23:55:53Z","timestamp":1525996553000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/110\/5\/501\/4621513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,14]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,11,14]]},"published-print":{"date-parts":[[2018,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djx225","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,5]]},"published":{"date-parts":[[2017,11,14]]}}}